LITTLE KNOWN FACTS ABOUT CONOLIDINE.

These outcomes, together with a preceding report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the strategy of targeting ACKR3 as a novel technique to modulate the opioid technique, which could open up new therapeutic avenues for opioid-connected Problems.Importantly, these receptors were obs